IgA nephropathy (IgAN) is the most common glomerular disease in the world. However, the
approach to treatment remains controversial. There has been an explosion of clinical trials …

ABSTRACT Introduction IgA nephropathy (IgAN) is the commonest primary
glomerulonephritis worldwide and may progress to end-stage kidney disease (ESKD) within …

An update on the treatment of IgA nephropathy : Current Opinion in Nephrology and
Hypertension An update on the treatment of IgA nephropathy : Current Opinion in …

IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide.
Recently, there have been multiple advances in the understanding of IgAN pathophysiology …

The pivotal event in the pathophysiology of IgA nephropathy is the binding of circulating IgA-
containing immune complexes to mesangial cells, with secondary glomerular and …

Objective: To review current literature regarding treatment options for immunoglobulin A
nephropathy (IgAN). Data Sources: A MEDLINE search was performed using the terms IgA …

International endeavors to improve the outcome of patients with IgA nephropathy have
produced evidencebased treatment recommendations and inspired efforts to develop novel …

IgA nephropathy remains the most common primary glomerular disease worldwide. It affects
children and adults of all ages, and is a leading cause of end-stage kidney disease, making …

Although IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis
worldwide, our understanding of the pathogenesis of this complex disease remains limited …

IgA nephropathy (IgAN) remains one of the most common forms of idiopathic
glomerulonephritis in many populations worldwide (1, 2). It also is a potentially serious …